Lupus & antiphospholipid syndrome
Lupus podocytopathy: A systematic review of clinical evidence from cases and cohorts
Authors' conclusion
LP is an uncommon but distinct manifestation of SLE with overall favorable outcome with treatment using systemic steroid and steroid-sparing agents.
Study context
- Population
- Systemic lupus erythematosus (SLE) patients with biopsy-proven lupus podocytopathy without features of class III, IV or V LN26 studies
Methodological detailsEMBASE and MEDLINE search
- EMBASE and MEDLINE search
Pooled result
As reported in the abstract
- Most patients were young females
- LP often part of the initial lupus manifestation, with nephrotic-range proteinuria
- Minimal change disease (MCD) the predominant pathology
- Overall favourable outcome with systemic steroid and steroid-sparing agents
Original publication
Lupus podocytopathy: A systematic review of clinical evidence from cases and cohorts. Lupus. Published 12 January 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →